QIMR Berghofer engages AI partner to fast-track cancer drug discovery
QIMR Berghofer is partnering with Korean-based company, Syntekabio, to use their leading artificial intelligence (AI)…
QIMR Berghofer is partnering with Korean-based company, Syntekabio, to use their leading artificial intelligence (AI)…
COPD, chronic obstructive pulmonary disease, is linked to a heightened risk of lung cancer in…
The controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be…